InvestED: The Rule #1 Investing Podcast · Phil Town & Danielle Town

Talking Terumo

·43 min·4 clips
Phil discovers a medical company that might have no competition in blood donation equipment.
Phil and Danielle open recording from Zurich around Thanksgiving week. The episode begins with a personal story: Phil mentioned to Danielle that a friend works at Terumo, and Danielle immediately asked whether it was a public company, signaling the reflex of applying investment thinking to everything. Phil describes having known about the company for years without ever thinking of it as an investment, illustrating his broader thesis that most people who work at publicly traded companies do not think of their employer as something they could own a piece of. Terumo is a Japanese company, listed on the Tokyo Stock Exchange, specializing in medical devices for blood handling: IV bags, blood collection equipment, blood bags for donation, and the ancillary components of those processes. Danielle's initial observation triggers Phil's attention: limited competition. Phil describes the moat question as central to Rule 1 investing in the Buffett tradition: a business with no meaningful competition can sustain pricing power over decades, whereas a business in a commoditized industry cannot. Terumo's products are medical-grade, subject to regulatory approval, and deeply embedded in hospital procurement relationships, all of which create switching costs. Phil notes that hospital systems are notoriously slow to change suppliers for critical-path equipment, meaning Terumo's market position may be stickier than the competitive picture alone suggests. The episode is structured as a real-time learning conversation: Phil and Danielle read from Terumo's public financial disclosures while discussing how to evaluate the numbers in the context of Rule 1 criteria including earnings growth rate, return on invested capital, and management quality. The tone is educational and warmly personal. The audience is individual investors learning Warren Buffett-style investing principles.

As heard by us

A plainspoken compounding lesson with enough back-and-forth to keep it human.

The episode follows a father-daughter investing conversation that turns a 15-year stock climb into a clear lesson about compounding and patience.

Read the full review in PlayNext →

Why you'd press play

See one stock turn into a live lesson on compounding.

Read the full recommendation in PlayNext →
Listen to the show on